HUISARTS EN WETENSCHAP Content Navigatie Servicelinks Zoeken
Blader huidige nummer

Blader huidige nummer

homeNHG: standaard

NHG: standaard

NHG-standaard Rectaal bloedverlies

Januari 2009

Huisarts en Wetenschap, jaargang 2009, nummer 1:23-38

Huisarts en Wetenschap jaargang 52, nummer 1 (2008) p. 23-38 Zie voor de tekst van NHG-Standaard de NHG-website: www.nhg.org.

  1. 1. Bij verwijzingen naar NHG-producten: zie http://www.nhg.org.
  2. 2. Acheson AG, Scholefield JH. Management of haemorrhoids. BMJ 2008;336:380-3.
  3. 3. Allen E, Nicolaidis C, Helfand M. The evaluation of rectal bleeding in adults. A cost-effectiveness analysis comparing four diagnostic strategies. J Gen Intern Med 2005;20:81-90.
  4. 4. Alonso Coello P, Mills E, Heels-Ansdell D, Lopez-Yarto M, Zhou Q, Johanson JF, et al. Fiber for the treatment of hemorrhoids complications: a systematic review and meta-analysis. Am J Gastroenterol 2006;101:181-8.
  5. 5. Alonso-Coello P, Castillejo MM. Office evaluation and treatment of hemorrhoids. J Fam Pract 2003;52:366-74.
  6. 6. Anonymus. Local preparations for ano-rectal symptoms. Drug Ther Bull 1969;7:41-3.
  7. 7. Anonymus. Alcohol. http://www.voedingscentrum.nl/EtenEnGezondheid/Voedingstoffen/alcohol/ . Geraadpleegd september 2008.
  8. 8. Aronson JK. Meyler's side effects of drugs: the international encyclopedia of adverse drug reactions and interactions. 15th ed. Amsterdam etc.: Elsevier, 2006.
  9. 9. Arroyo A, Perez F, Serrano P, Candela F, Lacueva J, Calpena R. Surgical versus chemical (botulinum toxin) sphincterotomy for chronic anal fissure: long-term results of a prospective randomized clinical and manometric study. Am J Surg 2005;189:429-34.
  10. 10. Bindewald H. Indikationen und Treffsicherheit der Rektoskopie. MMW Munch Med Wochenschr 1976;118:1271-2.
  11. 11. Briel JW, Zimmerman DD, Schouten WR. Treatment of acute strangulated internal hemorrhoids by topical application of isosorbide dinitrate ointment. Int J Colorectal Dis 2000;15:253-4.
  12. 12. Cohen RD, Woseth DM, Thisted RA, Hanauer SB. A meta-analysis and overview of the literature on treatment options for left-sided ulcerative colitis and ulcerative proctitis. Am J Gastroenterol 2000;95:1263-76.
  13. 13. Commissie Farmaceutische Hulp. Farmacotherapeutisch Kompas 2008. Amstelveen: College voor zorgverzekeringen, 2008.
  14. 14. Cook TA, Brading AF, Mortensen NJ. The pharmacology of the internal anal sphincter and new treatments of ano-rectal disorders. Aliment Pharmacol Ther 2001;15:887-98.
  15. 15. Crosland A, Jones R. Rectal bleeding: prevalence and consultation behaviour. BMJ 1995;311:486-8.
  16. 16. Cummings JR, Keshav S, Travis SP. Medical management of Crohn's disease. BMJ 2008;336:1062-6.
  17. 17. Daling JR, Madeleine MM, Johnson LG, Schwartz SM, Shera KA, Wurscher MA, et al. Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer. Cancer 2004;101:270-80.
  18. 18. De Gier JJ. Commentaren Medicatiebewaking 2006/2007. Houten: Stichting Health Base, 2006.
  19. 19. De Jong DJ, Nagengast FM. Opsporing van colorectaal carcinoom bij patienten met inflammatoir darmlijden. Ned Tijdschr Geneeskd 2007;151:2758-60.
  20. 20. Duffy MJ, Van Dalen A., Haglund C, Hansson L, Holinski-Feder E, Klapdor R, et al. Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use. Eur J Cancer 2007;43:1348-60.
  21. 21. Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 2001;48:526-35.
  22. 22. Ekbom A, Helmick C, Zack M, Adami HO. Increased risk of large-bowel cancer in Crohn's disease with colonic involvement. Lancet 1990;336:357-9.
  23. 23. Ellis BG, Thompson MR. Factors identifying higher risk rectal bleeding in general practice. Br J Gen Pract 2005;55:949-55.
  24. 24. Erlinger TP, Platz EA, Rifai N, Helzlsouer KJ. C-reactive protein and the risk of incident colorectal cancer. JAMA 2004;291:585-90.
  25. 25. Farrar WD, Sawhney MS, Nelson DB, Lederle FA, Bond JH. Colorectal cancers found after a complete colonoscopy. Clin Gastroenterol Hepatol 2006;4:1259-64.
  26. 26. Ferrari P, Jenab M, Norat T, Moskal A, Slimani N, Olsen A, et al. Lifetime and baseline alcohol intake and risk of colon and rectal cancers in the European prospective investigation into cancer and nutrition (EPIC). Int J Cancer 2007;121:2065-72.
  27. 27. Ferraris R, Senore C, Fracchia M, Sciallero S, Bonelli L, Atkin WS, et al. Predictive value of rectal bleeding for distal colonic neoplastic lesions in a screened population. Eur J Cancer 2004;40:245-52.
  28. 28. Fijten GH, Blijham GH, Knottnerus JA. Occurrence and clinical significance of overt blood loss per rectum in the general population and in medical practice. Br J Gen Pract 1994;44:320-5.
  29. 29. Fijten GH, Muris JW, Starmans R, Knottnerus JA, Blijham GH, Krebber TF. The incidence and outcome of rectal bleeding in general practice. Fam Pract 1993;10:283-7.
  30. 30. Fijten GH, Starmans R, Muris JW, Schouten HJ, Blijham GH, Knottnerus JA. Predictive value of signs and symptoms for colorectal cancer in patients with rectal bleeding in general practice. Fam Pract 1995;12:279-86.
  31. 31. Gonzalez EC, Roetzheim RG, Ferrante JM, Campbell R. Predictors of proximal vs. distal colorectal cancers. Dis Colon Rectum 2001;44:251-8.
  32. 32. Gorfine SR. Treatment of benign anal disease with topical nitroglycerin. Dis Colon Rectum 1995;38:453-6.
  33. 33. Greenspon J, Williams SB, Young HA, Orkin BA. Thrombosed external hemorrhoids: outcome after conservative or surgical management. Dis Colon Rectum 2004;47:1493-8.
  34. 34. Gupta P. Randomized, controlled study comparing sitz-bath and no-sitz-bath treatments in patients with acute anal fissures. ANZ J Surg 2006;76:718-21.
  35. 35. Hamilton W, Round A, Sharp D, Peters TJ. Clinical features of colorectal cancer before diagnosis: a population-based case-control study. Br J Cancer 2005;93:399-405.
  36. 36. Hamilton W, Sharp D. Diagnosis of colorectal cancer in primary care: the evidence base for guidelines. Fam Pract 2004;21:99-106.
  37. 37. Helfand M, Marton KI, Zimmer-Gembeck MJ, Sox HC, Jr. History of visible rectal bleeding in a primary care population. Initial assessment and 10-year follow-up. JAMA 1997;277:44-8.
  38. 38. Hodes B. Hemorrhoidal products. Handbook of nonprescription drugs. Washington: American Pharmaceutical Association, 1982: 641-55.
  39. 39. Hough DM, Malone DE, Rawlinson J, De Gara CJ, Moote DJ, Irvine EJ, et al. Colon cancer detection: an algorithm using endoscopy and barium enema. Clin Radiol 1994;49:170-5.
  40. 40. Hulme-Moir M, Bartolo DC. Hemorrhoids. Gastroenterol Clin North Am 2001;30:183-97.
  41. 41. Janssen LW. Consensus Hemorroiden. Ned Tijdschr Geneeskd 1994;138:2106-9.
  42. 42. Jaramillo E, Slezak P. Comparison between double-contrast barium enema and colonoscopy to investigate lower gastrointestinal bleeding. Gastrointest Radiol 1992;17:81-3.
  43. 43. Jensen SL. Treatment of first episodes of acute anal fissure: prospective randomised study of lignocaine ointment versus hydrocortisone ointment or warm sitz baths plus bran. Br Med J (Clin Res Ed) 1986;292:1167-9.
  44. 44. Jess T, Gamborg M, Matzen P, Munkholm P, Sorensen TI. Increased risk of intestinal cancer in Crohn's disease: a meta-analysis of population-based cohort studies. Am J Gastroenterol 2005;100:2724-9.
  45. 45. Jonas M, Scholefield J. Anal fissure (chronic). Clin Evid 2004;581-90.
  46. 46. Joosten AAM. Dermatica op recept. 3de herziene druk. Den Haag: Koninklijke Nederlandse Maatschappij ter bevordering der Pharmacie, 2006.
  47. 47. Kampman E, Nagengast FM. Dikkedarmkanker samengevat. RIVM, Bilthoven. http://www.rivm.nl/vtv/object_document/o1153n17273.html .
  48. 48. Koninklijke Nederlandse Maatschappij ter bevordering der Pharmacie. Informatorium Medicamentorum. Den Haag: KNMP, 2008.
  49. 49. Kwaliteitsinstituut voor de gezondheidszorg CBO. Herziene richtlijn Follow-up na poliepectomie. Utrecht: Kwaliteitsinstituut voor de gezondheidszorg, 2002.
  50. 50. Kwaliteitsinstituut voor de gezondheidszorg CBO. Conceptrichtlijn Diagnostiek en behandeling van inflammatoire darmziekten bij volwassenen. Utrecht: Kwaliteitsinstituut voor de gezondheidszorg, 2008a.
  51. 51. Kwaliteitsinstituut voor de gezondheidszorg CBO. Erfelijke darmkanker. Utrecht: Kwaliteitsinstituut voor de gezondheidszorg , 2008b.
  52. 52. Landelijke werkgroep Gastroenterologie-tumoren. Anuscarcinoom, landelijke richtlijn. http://www.oncoline.nl/index.php?pagina=/site/pagina.php&id=54321. Geraadpleegd augustus 2008.
  53. 53. Lawrenson R, Logie J, Marks C. Risk of colorectal cancer in general practice patients presenting with rectal bleeding, change in bowel habit or anaemia. Eur J Cancer Care (Engl) 2006;15:267-71.
  54. 54. Lee YJ, Lee HR, Nam CM, Hwang UK, Jee SH. White blood cell count and the risk of colon cancer. Yonsei Med J 2006;47:646-56.
  55. 55. Lewis JD, Brown A, Localio AR, Schwartz JS. Initial evaluation of rectal bleeding in young persons: a cost-effectiveness analysis. Ann Intern Med 2002;136:99-110.
  56. 56. Lieberman DA, Weiss DG, Harford WV, Ahnen DJ, Provenzale D, Sontag SJ, et al. Five-year colon surveillance after screening colonoscopy. Gastroenterology 2007;133:1077-85.
  57. 57. Madoff RD, Fleshman JW. AGA technical review on the diagnosis and care of patients with anal fissure. Gastroenterology 2003;124:235-45.
  58. 58. Metcalf JV, Smith J, Jones R, Record CO. Incidence and causes of rectal bleeding in general practice as detected by colonoscopy. Br J Gen Pract 1996;46:161-4.
  59. 59. Muris JWM. Aambeien/hemorroiden. In: Eekhof JAH, Knuistingh Neven A, Opstelten W, editors. Kleine kwalen in de huisartspraktijk. Maarssen: Elsevier Gezondheidszorg, 2007: 560-4.
  60. 60. Mustafa NA, Cengiz S, Turkyilmaz S, Yucel Y. Comparison of topical glyceryl trinitrate ointment and oral nifedipine in the treatment of chronic anal fissure. Acta Chir Belg 2006;106:55-8.
  61. 61. Nakama H, Kayano T, Katsuura T, Kamigaito T, Shimada S, Nishikawa N, et al. Comparison of predictive value for colorectal cancer in subjects with and without rectal bleeding. Hepatogastroenterology 1999;46:1730-2.
  62. 62. Nakama H, Zhang B, Abdul Fattah AS, Kamijo N, Fukazawa K. Relationships between a sign of rectal bleeding and the results of an immunochemical occult blood test, and colorectal cancer. Eur J Cancer Prev 2000;9:325-8.
  63. 63. Nelson R. Operative procedures for fissure in ano. Cochrane Database Syst Rev 2005;CD002199.
  64. 64. Nelson R. Non surgical therapy for anal fissure. Cochrane Database Syst Rev 2006;CD003431.
  65. 65. Nisar PJ, Scholefield JH. Managing haemorrhoids. BMJ 2003;327:847-51.
  66. 66. Norrelund N, Norrelund H. Colorectal cancer and polyps in patients aged 40 years and over who consult a GP with rectal bleeding. Fam Pract 1996;13:160-5.
  67. 67. Oh SW, Kim YH, Choi YS, Chang DK, Son HJ, Rhee PL, et al. The comparison of the risk factors and clinical manifestations of proximal and distal colorectal cancer. Dis Colon Rectum 2008;51:56-61.
  68. 68. Parellada C. Randomized, prospective trial comparing 0.2 percent isosorbide dinitrate ointment with sphincterotomy in treatment of chronic anal fissure: a two-year follow-up. Dis Colon Rectum 2004;47:437-43.
  69. 69. Pigot F, Siproudhis L, Allaert FA. Risk factors associated with hemorrhoidal symptoms in specialized consultation. Gastroenterol Clin Biol 2005;29:1270-4.
  70. 70. Pischon T, Lahmann PH, Boeing H, Friedenreich C, Norat T, Tjonneland A, et al. Body size and risk of colon and rectal cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC). J Natl Cancer Inst 2006;98:920-31.
  71. 71. Regueiro M, Loftus EV, Jr., Steinhart AH, Cohen RD. Medical management of left-sided ulcerative colitis and ulcerative proctitis: critical evaluation of therapeutic trials. Inflamm Bowel Dis 2006;12:979-94.
  72. 72. Robertson R, Campbell C, Weller DP, Elton R, Mant D, Primrose J, et al. Predicting colorectal cancer risk in patients with rectal bleeding. Br J Gen Pract 2006;56:763-7.
  73. 73. Rockey DC, Paulson E, Niedzwiecki D, Davis W, Bosworth HB, Sanders L, et al. Analysis of air contrast barium enema, computed tomographic colonography, and colonoscopy: prospective comparison. Lancet 2005;365:305-11.
  74. 74. Russel MG, Stockbrugger RW. Epidemiologische ontwikkelingen en inzichten met betrekking tot chronische inflammatoire darmziekten. Ned Tijdschr Geneeskd 2001;145:1448-52.
  75. 75. Sanchez A, Munoz C, Bujanda L, Iriondo C, Gil-Molet A, Cosme A, et al. The value of colonoscopy to assess rectal bleeding in patients referred from Primary Care Units. Rev Esp Enferm Dig 2005;97:870-6.
  76. 76. Smith RB, Moodie J. Comparative efficacy and tolerability of two ointment and suppository preparations ('Uniroid' and 'Proctosedyl') in the treatment of second degree haemorrhoids in general practice. Curr Med Res Opin 1988;11:34-40.
  77. 77. Stassen LPS, Schouten WR. Behandeling van chronisch fissura ani met nitraatzalf. Ned Tijdschr Geneeskd 1999;143:13.
  78. 78. Talley NJ, Jones M. Self-reported rectal bleeding in a United States community: prevalence, risk factors, and health care seeking. Am J Gastroenterol 1998;93:2179-83.
  79. 79. Thompson MR, Perera R, Senapati A, Dodds S. Predictive value of common symptom combinations in diagnosing colorectal cancer. Br J Surg 2007;94:1260-5.
  80. 80. Tseng HF, Morgenstern H, Mack TM, Peters RK. Risk factors for anal cancer: results of a population-based case-control study. Cancer Causes Control 2003;14:837-46.
  81. 81. Van den Berg M, Stroeken HJ, Hoofwijk AG. Gunstige resultaten van conservatieve behandeling met isosorbidedinitraat van 25 patiënten met graad-4-hemorroiden: een pilotstudie. Ned Tijdschr Geneeskd 2003;147:971-3.
  82. 82. Van der Linden MW, Westert GP, De Bakker DH, Schellevis FG. Tweede Nationale Studie naar ziekten en verrichtingen in de huisartspraktijk: klachten en aandoeningen in de bevolking en in de huisartspraktijk. Utrecht/Bilthoven: NIVEL/RIVM, 2004.
  83. 83. Van der Meer J, Stehouwer CDA. Interne geneeskunde. Houten: Bohn Stafleu van Loghum, 2005.
  84. 84. Van Rijn JC, Reitsma JB, Stoker J, Bossuyt PM, Van Deventer SJ, Dekker E. Polyp miss rate determined by tandem colonoscopy: a systematic review. Am J Gastroenterol 2006;101:343-50.
  85. 85. Vermeire S, Van Assche G, Rutgeerts P. Laboratory markers in IBD: useful, magic, or unnecessary toys? Gut 2006;55:426-31.
  86. 86. Weiss W, Hanak H, Huber A. Effizienz der rektal-digitalen Untersuchung zur Fruherkennung des Dickdarmkarzinoms. Wien Klin Wochenschr 1977;89:654-60.
  87. 87. Werre AJ, Palamba HW, Bilgen EJ, Eggink WF. Isosorbide dinitrate in the treatment of anal fissure: a randomised, prospective, double blind, placebo-controlled trial. Eur J Surg 2001;167:382-5.
  88. 88. Wigersma L. Adviezen bij aambeien en pruritis ani: waarheden en mythen. Huisarts Wet 1997;40:204-9.
  89. 89. Witte ME, Klaase JM. Gunstige resultaten van lokale injectie met botuline A toxine bij patienten met chronische anale fissuren die niet reageren op behandeling met isosorbidedinitraat. Ned Tijdschr Geneeskd 2006;150:1513-7.
Reacties

lees alle reacties (totaal 0) »

Dit artikel:

Interactief

  • Reageer
  • Lees reacties
  • Stuur door
  • Bewaar
  • Print
  • Mail mij de reacties
  • Voeg artikel toe aan:

Alles over

Zie ook

Zoeken

Zoek binnen: Uitgebreid zoeken

Inloggen
Wachtwoord vergeten?

Abonneren

Meest gelezen

Meer artikelen »
 

Medisch nieuws

Meer Medisch nieuws »
 

Nederlands Huisartsen Genootschap

 

Navigatie

Service

nederlands huisartsen genootschap Bohn Stafleu van Loghum

Copyright © 2012 Bohn Stafleu van Loghum. All rights reserved.